Application

17850875 · METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY

Filed 2022-06-27 · Abandoned The official file ↗ · Art unit 1634 · Examiner Anne Marie Sabrina Wehbe Typical · CPC A61K 40/31 · Juno Therapeutics, Inc. · Bristol-Myers Squibb Company

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

36.5 mo

to disposition 49.5 mo

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.